Clinical Trial Detail

NCT ID NCT02365597
Title An Efficacy and Safety Study of JNJ-42756493 in Participants With Urothelial Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors Janssen Research & Development, LLC
Indications

urinary system cancer

Therapies

Erdafitinib

Age Groups: adult

No variant requirements are available.